<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/department/DEPARTMENT_OF_HEALTH_AND_HUMAN_SERVICES/2008-01-02/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Sun, May 19 2013 11:00:00 GMT</pubDate>
    <lastBuildDate>Sun, May 19 2013 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Disease, Disability, and Injury Prevention and Control Special  Emphasis Panel (SEP): National Institute for]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-E7-25544</link>
  <description><![CDATA[
</p><p>    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92463), the Centers for Disease Control and  Prevention (CDC) announces the aforementioned meeting.</p><p>    Time and Date: 8:30 a.m.5:30 p.m., February 20, 2008 (Closed).
</p><p>    Place: Marriott Marina del Rey, 4100 Admiralty Way, Marian del  Rey, CA 90292.</p>
<h3>[[Page 191]]</h3>
<p>    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis  and Services Office, CDC, pursuant to Public Law 92463.</p><p>    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``National Institute for Occupational 
Safety and Health (NIOSH): Occupational Safety and Health Training  Project Grants, PA PAR06484.''</p><p>    Contact Person for More Information: Charles N. Rafferty, PhD, 
Assistant Director for Review and Policy, Office of Extramural 
Programs, Office of Extramural Coordination and<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-E7-25544</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Mine Safety and Health Research Advisory Committee (MSHRAC):  Meeting]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-E7-25509</link>
  <description><![CDATA[
</p><p>    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned  committee:<br/> </p><p>    Time and Date:<br/> </p><p>    8:45 a.m.5:15 p.m., January 22, 2008.<br/> </p><p>    8:30 a.m.3:45 p.m., January 23, 2008.</p><p>    Place: Hilton Garden Inn Pittsburgh/Southpointe, 1000 Corporate 
Drive, Canonsburg, PA 15317, telephone (724) 7435000, fax (724)  7435010.</p><p>    Status: The meeting room accommodates approximately 50 people.
</p><p>    Purpose: This committee is charged with providing advice to the 
Secretary, Department of Health and Human Services; the Director, 
CDC; and the Director, NIOSH, on priorities in mine safety and 
health research, including grants and contracts for such research,  30 U.S.C. 812(b)(2), Section 102(b)(2).</p><p>    Matters To Be Discussed: The meeting will focus on 
Communications and Tracking, update on Refuge Alternatives 
Activities, Mine Ground Control Research, Dynamic Failures Proposal, 
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-E7-25509</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Center for Food Safety and Applied Nutrition; Statement of  Organization, Functions, and Delegations of Authority]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-07-6257</link>
  <description><![CDATA[
</p><p>    Part D, Food and Drug Administration, Chapter DB, Office of 
Operations, Center for Food Safety and Applied Nutrition (DBF), of the 
Statement of Organization, Functions, and Delegations of Authority for 
the Department of Health and Human Services (35 FR 3685, February 25, 
1970, and 60 FR 56005, November 9, 1995; 64 FR 36361, July 6, 1999; and 
in pertinent part at 57 FR 54239) is amended to reflect the 
restructuring of the Center for Food Safety and Applied Nutrition 
(CFSAN), Office of Operations (OO), Food and Drug Administration (FDA)  as follows:</p><p>    I. Under Chapter DB, Office of Operations, delete in its entirety,  the ``Center for Food Safety and Applied Nutrition (DBF).</p><p>    II. Establish a new Chapter DH, Center for Food Safety and Applied  Nutrition (DH), under Part D to read as follows:</p><p>    DF.10 Organization. The Center for Food Safety and Applied 
Nutrition, FDA is headed by the Director, Food Safety and Applied 
Nutrition, and includes the following organizational units:
Office of the Ce<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-07-6257</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Guidance for Industry and Food and Drug Administration;  Interactive Review for Medical Device Submissions: 510(k)s,]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-07-6268</link>
  <description><![CDATA[  The Food and Drug Administration (FDA) is announcing the 
availability of the guidance entitled ``Interactive Review for Medical 
Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original 
BLAs, and BLA Supplements.'' The purpose of this guidance document is  to recommend an<br/> [[Page 195]]<br/>
interactive premarket review process for these submissions that is 
designed to expedite FDA's review of device applications while 
continuing to assure device safety and effectiveness, in accordance 
with the goals of the Food and Drug Administration Amendments Act of 
2007 (FDAAA).
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-07-6268</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Draft Guidance for Industry on Questions and Answers Regarding  the Labeling of Nonprescription Human Drug Products]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-07-6267</link>
  <description><![CDATA[  The Food and Drug Administration (FDA) is announcing the 
availability of a draft guidance entitled ``Questions and Answers 
Regarding the Labeling of Nonprescription Human Drug Products Marketed 
Without an Approved Application as Required by the Dietary Supplement 
and Nonprescription Drug Consumer Protection Act.'' This draft guidance 
is intended to assist industry in complying with the labeling 
requirements for nonprescription (overthecounter (OTC)) human drugs 
marketed without an approved application established by the Dietary 
Supplement and Nonprescription Drug Consumer Protection Act. Separate 
guidance, issued by the Center for Food Safety and Applied Nutrition on 
labeling requirements for dietary supplements, is announced elsewhere 
in this issue of the Federal Register.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-07-6267</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Draft Guidance for Industry: Questions and Answers Regarding the  Labeling of Dietary Supplements as Required by the]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-07-6266</link>
  <description><![CDATA[  The Food and Drug Administration (FDA) is announcing the 
availability of a draft guidance entitled ``Questions and Answers 
Regarding the Labeling of Dietary Supplements as Required by the 
Dietary Supplement and Nonprescription Drug Consumer Protection Act.'' 
This draft guidance is intended to assist the dietary supplement 
industry in complying with the labeling requirements prescribed for 
dietary supplement manufacturers, packers, and distributors by the 
Dietary Supplement and Nonprescription Drug Consumer Protection Act 
(the DSNDCPA). Separate guidance, issued by the Center for Drug 
Evaluation and Research on labeling requirements for nonprescription  (overthecounter) human drugs marketed without an approved <br/>
application, is announced elsewhere in this issue of the Federal 
Register.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-07-6266</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Agency Information Collection Request. 60-Day Public Comment  Request]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-E7-25428</link>
  <description><![CDATA[<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-E7-25428</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[
Request for Information and Comments on Research That Involves  Adult Individuals With Impaired Decision-Making]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-E7-25460</link>
  <description><![CDATA[ On September 5, 2007, the Office for Human Research 
Protections, Office of Public Health and Science, Office of the 
Secretary, Department of Health and Human Services (HHS) issued a 
notice in the Federal Register (Vol. 72, No. 171, pages 5096650970) 
seeking information and comments about whether guidance or additional 
regulations are needed to adequately protect adult individuals with 
impaired decisionmaking capacity who are potential subjects in 
research. A 90day comment period was established upon publication of  that notice.</p><p>    The purpose of this notice is to inform all interested parties that 
the comment period originally identified in the September 5, 2007 
Federal Register has been extended for forty one days, in order to 
maximize the opportunity for interested individuals and organizations 
to provide information and comments to HHS on this topic.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-E7-25460</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Agency Information Collection Activities: Submission for OMB  Review; Comment Request]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-E7-25386</link>
  <description><![CDATA[
</p><p>    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 2761243.
Proposed Project: 2008 National Survey of Mental Health Treatment  Facilities (NSMHTF) (OMB No. 09300119)Revision</p><p>    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Mental Health Services (CMHS) will conduct a 2008 
NSMHTF. This national survey represents a redesign of the biennial 
Survey of Mental Health Organizations (SMHO) last conducted in 2004 
under OMB No. 09300119. Instead of surveying each mental health 
organization as a whole, the 2008 NSMHTF will survey all of the mental 
health treatment locations. These separate mental health service 
locations are called facilities, in contrast to mental health 
organizations, which may inc<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-E7-25386</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Agency Information Collection Activities: Proposed Collection;  Comment Request]]></title>
  <link>http://thefederalregister.com/d.p/2008-01-02-07-6254</link>
  <description><![CDATA[
</p><p>    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the  SAMHSA Reports Clearance Officer on (240) 2761243.</p><p>    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniq<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2008-01-02-07-6254</guid>
  <pubDate>Wed, Jan 2 2008 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

